Sunshine Biopharma Inc. (SBFMW) Total liabilities 2017–2025
Sunshine Biopharma Inc. (SBFMW) total liabilities at each fiscal year-end, per SEC filings.
$7.0MFY2025 · since FY2017: $830,848 → $7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.0M | -0.3% |
| FY2024 | $7.1M | +15.0% |
| FY2023 | $6.1M | -19.4% |
| FY2022 | $7.6M | +282.5% |
| FY2021 | $2.0M | -0.5% |
| FY2020 | $2.0M | +140.0% |
| FY2019 | $833,527 | -30.7% |
| FY2018 | $1.2M | +44.7% |
| FY2017 | $830,848 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice